Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

92 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Diagnostic criteria for the classification of cancer-associated weight loss.
Martin L, Senesse P, Gioulbasanis I, Antoun S, Bozzetti F, Deans C, Strasser F, Thoresen L, Jagoe RT, Chasen M, Lundholm K, Bosaeus I, Fearon KH, Baracos VE. Martin L, et al. Among authors: Senesse P. J Clin Oncol. 2015 Jan 1;33(1):90-9. doi: 10.1200/JCO.2014.56.1894. Epub 2014 Nov 24. J Clin Oncol. 2015. PMID: 25422490
RESULTS: Mean overall %WL was -9.7% ± 8.4% and BMI was 24.4 ± 5.1 kg/m(2), and both %WL and BMI independently predicted survival (P < .01). Differences in survival were observed across five categories of BMI (< 20.0, 20.0 to 21.9, 22.0 to 24.9, 25.0 to 27.9, and ≥ 28.0 kg/m(2); P < .001) and five categories of %WL (-2.5% to -5.9%, -6.0% to -10.9%, -11.0% to -14.9%, ≥ -15.0%, and weight stable (± 2.4%); P < .001). ...
RESULTS: Mean overall %WL was -9.7% ± 8.4% and BMI was 24.4 ± 5.1 kg/m(2), and both %WL and BMI independently predicted survival (P & …
Nutritional assessment in overweight and obese patients with metastatic cancer: does it make sense?
Gioulbasanis I, Martin L, Baracos VE, Thézénas S, Koinis F, Senesse P. Gioulbasanis I, et al. Among authors: Senesse P. Ann Oncol. 2015 Jan;26(1):217-21. doi: 10.1093/annonc/mdu501. Epub 2014 Oct 30. Ann Oncol. 2015. PMID: 25361991
A significant difference in overall survival was found between groups [group A 17.8 (15.5-20.1) months, group B 8.2 (7.3-9.3) months, and group C 6.4 (3.2-9.6) months, P < 0.001]. ...
A significant difference in overall survival was found between groups [group A 17.8 (15.5-20.1) months, group B 8.2 (7.3-9.3) months, and gr …
Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres.
Pressoir M, Desné S, Berchery D, Rossignol G, Poiree B, Meslier M, Traversier S, Vittot M, Simon M, Gekiere JP, Meuric J, Serot F, Falewee MN, Rodrigues I, Senesse P, Vasson MP, Chelle F, Maget B, Antoun S, Bachmann P. Pressoir M, et al. Among authors: Senesse P. Br J Cancer. 2010 Mar 16;102(6):966-71. doi: 10.1038/sj.bjc.6605578. Epub 2010 Feb 16. Br J Cancer. 2010. PMID: 20160725 Free PMC article. Clinical Trial.
Antibiotics use was significantly higher in malnourished patients (35.5 vs 22.8%; P<0.001). Severe malnutrition was independently associated with mortality. The median length of stay was 19.3+/-19.4 days for malnourished patients vs 13.3+/-19.4 days for others (P<0.0001). CONCLUSION: In French Comprehensive Cancer Centres, one out of three cancer patients are malnourished and this was associated with a longer length of stay. ...
Antibiotics use was significantly higher in malnourished patients (35.5 vs 22.8%; P<0.001). Severe malnutrition was independently …
Management of Cancer Cachexia and Guidelines Implementation in a Comprehensive Cancer Center: A Physician-Led Cancer Nutrition Program Adapted to the Practices of a Country.
Senesse P, Isambert A, Janiszewski C, Fiore S, Flori N, Poujol S, Arroyo E, Courraud J, Guillaumon V, Mathieu-Daudé H, Colasse S, Baracos V, de Forges H, Thezenas S. Senesse P, et al. J Pain Symptom Manage. 2017 Sep;54(3):387-393.e3. doi: 10.1016/j.jpainsymman.2017.01.010. Epub 2017 Aug 1. J Pain Symptom Manage. 2017. PMID: 28778558
Liver metastases in prostate carcinoma: clinical characteristics and outcome.
Pouessel D, Gallet B, Bibeau F, Avancès C, Iborra F, Sénesse P, Culine S. Pouessel D, et al. Among authors: Senesse P. BJU Int. 2007 Apr;99(4):807-11. doi: 10.1111/j.1464-410X.2006.06663.x. Epub 2006 Nov 28. BJU Int. 2007. PMID: 17155968
A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5 FU2 + irinotecan or LV5 FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le Cancer.
Bécouarn Y, Senesse P, Thézenas S, Boucher E, Adenis A, Cany L, Jacob JH, Cvitkovic F, Montoto-Grillot C, Ychou M; Digestive Group of the Fédération Nationale des Centres de Lutte Contre le Cancer. Bécouarn Y, et al. Among authors: Senesse P. Ann Oncol. 2007 Dec;18(12):2000-5. doi: 10.1093/annonc/mdm379. Epub 2007 Sep 4. Ann Oncol. 2007. PMID: 17785765 Clinical Trial.
Restorative and nonrestorative surgery for low rectal cancer after high-dose radiation: long-term oncologic and functional results.
Rouanet P, Saint-Aubert B, Lemanski C, Senesse P, Gourgou S, Quenet F, Ycholu M, Kramar A, Dubois J. Rouanet P, et al. Among authors: Senesse P. Dis Colon Rectum. 2002 Mar;45(3):305-13; discussion 313-5. doi: 10.1007/s10350-004-6172-6. Dis Colon Rectum. 2002. PMID: 12068185 Clinical Trial.
The univariate analysis underscores the tumor response impact on long-term survival (pT<3 = 81 percent; pT3 = 35 percent; P = 0.0008). ...
The univariate analysis underscores the tumor response impact on long-term survival (pT<3 = 81 percent; pT3 = 35 percent; P = 0.00 …
Clinical impact of lymph node status in rectal cancer.
Colombo PE, Patani N, Bibeau F, Assenat E, Bertrand MM, Senesse P, Rouanet P. Colombo PE, et al. Among authors: Senesse P. Surg Oncol. 2011 Dec;20(4):e227-33. doi: 10.1016/j.suronc.2011.08.004. Epub 2011 Sep 10. Surg Oncol. 2011. PMID: 21911287 Review.
92 results
Jump to page
Feedback